Serina Therapeutics
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -18 | -3,401 | -3,651 | |
EBITDA | -7,415 | -7,062 | -3,096 | -4,573 |
EBIT | -7,080 | -3,120 | -4,589 | |
Net Income | -6,356 | -6,898 | -3,336 | -4,585 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -6,684 | -4,593 | -6,033 | -3,863 |
Cash | 23,024 | 24,526 | 3,056 | 8,620 |
Basic Shares | 16,385 | 12,047 | 10,190 | 10,339 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $130 | $56 | $3,153 | $500 |
Gross Profit | 45 | -138 | 3,063 | 500 |
EBITDA | -18,911 | -10,487 | 5,917 | -2,604 |
EBIT | -18,984 | -10,681 | 5,827 | -2,666 |
Net Income | -19,182 | -11,141 | 5,269 | -2,682 |
Net Change In Cash | 130 | 56 | 3,153 | 500 |
Free Cash Flow | -17,955 | -17,159 | -2,980 | -2,085 |
Cash | 3,056 | 3,672 | 7,619 | 645 |
Basic Shares | 10,190 | 7,359 | 8,413 | 1,078 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.55 |
2026-03-31 | -$0.53 |
2025-12-31 | -$0.31 |
2025-09-30 | -$0.51 |